Optimal Integration of TROP2-Directed ADCs Into Treatment Regimens for Patients With Non-Small-Cell Lung Cancer (NSCLC)
Optimal Integration of TROP2-Directed ADCs Into Treatment Regimens for Patients With Non-Small-Cell Lung Cancer (NSCLC)
Point-of-Care LearningExpiration Date: October 31, 2024
CME/CE is no longer available for this activity